Bionano Genomics Inc. [NASDAQ: BNGO] traded at a high on 10/17/22, posting a 1.46 gain after which it closed the day’ session at $2.08. The company report on October 14, 2022 that OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability to Detect Chromosomal Structural Variations Found in Recurrent Pregnancy Loss.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
In a case study from Hangzhou Maternity and Child Care Hospital, researchers analyzed samples from a pregnant subject who had an abnormal NIPT result in her second pregnancy, after experiencing a spontaneous abortion the prior year. The study sought to determine OGM’s utility for detection of chromosome breakages and fusions found in complex chromosomal rearrangements (CCR), which can significantly increase an abnormal pregnancy outcome for carrier couples. The study reports that about 70% of CCR carriers are phenotypically normal, but they have a high risk of recurrent miscarriage, subfertility or infertility, and pregnancy abnormalities due to conceiving offspring with unbalanced CCRs.
The results of the trading session contributed to over 5495337 shares changing hands. Over the past one week, the price volatility of Bionano Genomics Inc. stands at 10.26% while the volatility over the past one month is 8.30%.
The market cap for BNGO stock reached $665.29 million, with 285.55 million shares outstanding and 284.59 million shares in the current float. Compared to the average trading volume of 8.12M shares, BNGO reached a trading volume of 5495337 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bionano Genomics Inc. [BNGO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $11.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 1.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Bionano Genomics Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 18, 2022. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on June 16, 2021, representing the official price target for Bionano Genomics Inc. stock. Previously, the target price had yet another raise to $1.25, while Ladenburg Thalmann analysts kept a Buy rating on BNGO stock.
The Average True Range (ATR) for Bionano Genomics Inc. is set at 0.18, with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 28.55. The Price to Book ratio for the last quarter was 2.08, with the Price to Cash per share for the same quarter was set at 0.59.
How has BNGO stock performed recently?
Bionano Genomics Inc. [BNGO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.58. With this latest performance, BNGO shares dropped by -6.73% in over the last four-week period, additionally plugging by 8.33% over the last 6 months – not to mention a drop of -59.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNGO stock in for the last two-week period is set at 48.48, with the RSI for the last a single of trading hit 49.80, and the three-weeks RSI is set at 48.28 for Bionano Genomics Inc. [BNGO]. The present Moving Average for the last 50 days of trading for this stock 2.39, while it was recorded at 2.13 for the last single week of trading, and 2.06 for the last 200 days.
Bionano Genomics Inc. [BNGO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Bionano Genomics Inc. [BNGO] shares currently have an operating margin of -428.79 and a Gross Margin at +4.47. Bionano Genomics Inc.’s Net Margin is presently recorded at -402.84.
Return on Equity for this stock declined to -38.92, with Return on Assets sitting at -33.11.
Bionano Genomics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.00 and a Current Ratio set at 7.80.
Insider trade positions for Bionano Genomics Inc. [BNGO]
There are presently around $171 million, or 28.80% of BNGO stock, in the hands of institutional investors. The top three institutional holders of BNGO stocks are: BLACKROCK INC. with ownership of 21,021,575, which is approximately 13.046% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 15,634,397 shares of the stock with an approximate value of $32.52 million in BNGO stocks shares; and STATE STREET CORP, currently with $17.5 million in BNGO stock with ownership of nearly 8.944% of the company’s market capitalization.
Positions in Bionano Genomics Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 64 institutional holders increased their position in Bionano Genomics Inc. [NASDAQ:BNGO] by around 13,805,215 shares. Additionally, 67 investors decreased positions by around 4,051,384 shares, while 50 investors held positions by with 64,589,904 shares. The mentioned changes placed institutional holdings at 82,446,503 shares, according to the latest SEC report filing. BNGO stock had 24 new institutional investments in for a total of 1,844,946 shares, while 21 institutional investors sold positions of 647,115 shares during the same period.